(Reuters) - Sanofi said on Tuesday it had hired former Roche top scientist John Reed to head its research operations from July 1, when Elias... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/jASySIZMSl0/ex-roche-scientist-reed-to-head-sanofi-rd-as-zerhouni-retires-idINKBN1HV0MQ
(Reuters) - Pfizer Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve the company's biosimilar to Roche's breast... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/jtSg16HLetI/fda-declines-to-approve-pfizers-biosimilar-to-roches-cancer-drug-idINKBN1HU1KN
ZURICH (Reuters) - Roche's hemophilia A drug Hemlibra will get an accelerated review by U.S. regulators for use in a new group of patients, a key... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/r7yjAPRbZbs/roches-hemlibra-gets-speedy-fda-review-for-wider-use-idINKBN1HO0ID
Tecentriq has shown to extend survival and improve the quality of life in the approved indications, Roche said in a statement. The product has been... ...https://www.moneycontrol.com/news/business/roche-launches-new-lung-bladder-cancer-drugindia_10740801.html
ZURICH (Reuters) - A Tokyo court has ruled that Shire's claim against Swiss drugmaker Roche's new Hemlibra hemophilia medicine should be dismissed,... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/o0UMxIhJaRU/tokyo-court-rejects-shire-claim-against-roche-hemophilia-drug-idINKBN1H40PS
Roche is a Emerging company as a IVR...